TickerFacts.

Kestra Medical Technologies, Ltd. (KMTS): Gross Profit

Annual figures by period end, from SEC filings.

$48.86M
Year ended 2026-04-30
$57.51M
Trailing 12 months to 2026-07-31
2024-04-30: $362.0K2025-04-30: $24.21M2026-04-30: $48.86M$48.86M
2024-04-30 Gross Profit (USD) 2026-04-30
Period endedGross ProfitChange YoYSource filing
2026-04-30$48.86M+101.8%2026-07-14, From 2025-05-01
2025-04-30$24.21Mn/m2026-07-14, From 2024-05-01
2024-04-30$362.0Kn/a2025-07-17, From 2023-05-01

Gross Profit at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30$48.86M+101.8%
NeuroPace Inc (NPCE)2025-12-31$77.22M+30.7%
Pulmonx Corp (LUNG)2025-12-31$67.14M+8.3%
Beta Bionics, Inc. (BBNX)2025-12-31$55.54M+54.8%
Delcath Systems, Inc. (DCTH)2025-12-31$73.43M+136.8%
Iradimed Corp (IRMD)2025-12-31$64.32M+14.2%
TELA Bio, Inc. (TELA)2025-12-31$54.34M+16.9%
Anika Therapeutics, Inc. (ANIK)2025-12-31$63.81M-16.0%
Orasure Technologies Inc (OSUR)2025-12-31$48.20M-39.3%

Compare KMTS, NPCE, LUNG, BBNX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗